SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 116 filers reported holding SUTRO BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is 2.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $237,084 | -9.8% | 68,324 | +20.9% | 0.00% | 0.0% |
| Q2 2023 | $262,837 | +24.1% | 56,524 | +23.3% | 0.00% | 0.0% |
| Q1 2023 | $211,845 | -58.5% | 45,854 | -27.4% | 0.00% | -50.0% |
| Q4 2022 | $510,042 | +33.9% | 63,124 | -8.1% | 0.00% | 0.0% |
| Q3 2022 | $381,000 | +6.4% | 68,684 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $358,000 | +6.2% | 68,684 | +67.5% | 0.00% | +100.0% |
| Q1 2022 | $337,000 | -44.8% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $610,000 | -21.3% | 41,004 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $775,000 | -4.7% | 41,004 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $813,000 | +172.8% | 43,754 | +47.6% | 0.00% | +300.0% |
| Q3 2020 | $298,000 | +61.1% | 29,641 | +24.3% | 0.00% | 0.0% |
| Q2 2020 | $185,000 | – | 23,854 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $27,149,000 | 17.55% |
| Samsara BioCapital, LLC | 1,675,579 | $24,933,000 | 4.84% |
| AJU IB Investment Co., Ltd. | 175,000 | $2,604,000 | 3.63% |
| First Light Asset Management, LLC | 2,246,588 | $33,429,000 | 2.39% |
| Opaleye Management Inc. | 680,000 | $10,118,000 | 2.15% |
| FRAZIER MANAGEMENT LLC | 1,776,479 | $26,434,000 | 2.04% |
| Connective Portfolio Management, LLC | 35,000 | $527,000 | 0.93% |
| Parkman Healthcare Partners LLC | 221,219 | $3,292,000 | 0.73% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,437,795 | $36,274,000 | 0.70% |
| Eventide Asset Management | 2,708,975 | $40,310,000 | 0.52% |